Andrew Joseph, STAT

Andrew Joseph

STAT

Boston, MA, United States

Contact Andrew

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • STAT
Past:
  • Boston.com
  • The Boston Globe
  • Scientific American
  • Fox News
  • Mashable
  • Tech Insider
  • mySA
  • Beaumont Enterprise
  • Houston Chronicle

Recent articles by Andrew:

What the current spike in Covid-19 cases could say about the coronavirus’ future

As the Omicron wave subsided in the United States earlier this year, many experts anticipated a sort of reprieve. That break now seems to be over. → Read More

With Omicron, nearly 60% in U.S. have been infected during pandemic

Nearly 60% of people in the United States, including three in four children, have now been infected with Omicron or another coronavirus variant, data released Tuesday show. → Read More

A rabid anteater was moved from one zoo to another, leading to rabies treatment for 13 people

The transport of an anteater from one zoo to another may have exposed more than a dozen people to rabies, researchers said, serving as a warning that such transfers can expand what are considered “rabies zones.” → Read More

U.S. approves second Covid-19 booster for people 50 and older

People 50 and older are now eligible for another shot of either the Pfizer-BioNTech and Moderna mRNA vaccines four months after their last dose, the FDA said. → Read More

Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron

U.S. health officials limited the deployment of the Covid-19 antibody therapy sotrovimab, given laboratory studies showing the treatment likely doesn’t work against the BA.2 coronavirus variant. → Read More

With infections spiking in Europe and a variant on the rise, experts warn the U.S. could face a Covid resurgence

With infections spiking in Europe and a variant on the rise, experts warn the U.S. should prepare for a Covid resurgence, even if it turns out to be minor. → Read More

In a victory for pain experts, CDC tones down its opioid prescribing guidelines

Federal health officials abandoned their influential recommendations that opioid prescribers should aim for certain dose thresholds when treating chronic pain. → Read More

Omicron’s sister variant spreads faster. So why did the one we call Omicron hit first?

We know that the best-spreading coronavirus variant will outcompete any slowpokes. But something curious happened with Omicron: The more transmissible variant didn’t take off first. → Read More

Early data indicate vaccines still protect against Omicron’s sister variant, BA.2

New data show that vaccines still protect against a spinoff of the Omicron variant, a welcome sign as the world keeps a close eye on the latest coronavirus iteration. → Read More

Hospitals are denying transplants for patients who aren’t vaccinated against Covid, with backing from ethicists

Hospitals are denying transplants for patients who aren’t vaccinated against Covid, with backing from ethicists. → Read More

It’s too early to tell whether CBD helps against Covid-19 — but researchers worry that won’t stop CBD makers

It’s too early to tell whether CBD helps against Covid-19 — but researchers worry that won’t stop CBD makers. → Read More

New data show those who recovered from Covid-19 were less likely than vaccinated to get infected during Delta wave

New data show those who recovered from Covid-19 were less likely than vaccinated people to get infected during the Delta wave. But the data contain caveats that stress the value of vaccination, even with prior infection, experts said. → Read More

Doctors have an arsenal of Covid-19 treatments, but setbacks and shortages are undercutting options

Doctors have an arsenal of different Covid-19 treatments, but setbacks and shortages are undercutting the options. → Read More

Beyond case counts: What Omicron is teaching us

Experts say the U.S. has a ways to go to get through the Omicron surge. Here, STAT outlines what Omicron is already teaching us as this phase of the pandemic plays out. → Read More

CDC data indicate Omicron is starting to eat into Delta's U.S. dominance

New CDC data show that the Omicron coronavirus variant is starting to eat into the Delta variant’s dominance in the U.S. → Read More

Omicron can likely outcompete Delta, which would worsen Covid in U.S.

Omicron is picking up speed in Europe, which has often served as a preview of what is heading the U.S.’s way. → Read More

Pfizer-BioNTech Covid-19 shot loses power against Omicron variant

At the same time, the data suggest a booster should allow someone to mount enough of a response to restore overall protection against Omicron. → Read More

First, small study suggests Omicron is a larger threat to Covid-19 immunity

A small, preliminary study has found a significant drop in how well vaccine-elicited antibodies target the Omicron variant of the coronavirus. → Read More

First, small study suggests Omicron is a larger threat to Covid-19 immunity

A small, preliminary study has found a significant drop in how well vaccine-elicited antibodies target the Omicron variant of the coronavirus. → Read More

How to interpret the coming data on Omicron and Covid immunity

We’ll know more soon about Omicron and immune protection. Here’s how to interpret the coming flood of data. → Read More